Dr. Evanthia Galanis, MD

Dr. Galanis practices at Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota.

Dr. Galanis' NPI, 1326028234, was assigned on January 18, 2006. Dr. Galanis graduated from University of Athens in 1990. Dr. Galanis' Minnesota license number on file is 36286.

Dr. Galanis' primary practice is Mayo Clinic Breast Diagnostic Clinic, at 200 First Street SW, Rochester, MN 55905. The practice phone is (507) 284-5968.

Dr. Galanis' primary practice is Mayo Clinic Breast Diagnostic Clinic in Rochester, Minnesota. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Galanis to 1 more clinical lab and 1 hospice, each named with a free account. Dr. Galanis' employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Galanis practices, 3 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Galanis' primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Galanis is board certified in medical oncology by the American Board of Internal Medicine. Dr. Galanis has a license on file in Minnesota.

Dmand AI lists colorectal cancer and lung cancer among the conditions Dr. Galanis treats.

CMS data shows 23,812 Medicare services from Dr. Galanis across 26 procedure codes in 2024, for 241 Medicare patients. Medicare paid $487,928 for them. Every service was in an office.

CMS counts 241 Medicare patients who saw Dr. Galanis in 2024. The largest group is 65 to 74, with 132 patients. 64% of them have high blood pressure, and 60% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Galanis' median patient age at 66, with 52% women.

In 2024, Dr. Galanis wrote 12 Medicare Part D claims. 100% of them were for generic drugs.

Dr. Galanis accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 267 papers to Dr. Galanis, published from 2005 to 2025. 2019 was the busiest year, with 11. The most frequent topics are Brain Neoplasms, Measles virus and Oncolytic Virotherapy. Dr. Galanis has published most often in Neuro Oncol. Dr. Galanis' most frequent co-authors are Jan C. Buckner, MD, Kurt Alfred Jaeckle, MD and Paul D. Brown, MD.

Dmand AI links Dr. Galanis to 21 clinical trials, 12 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Glioblastoma, Gliosarcoma and Oligodendroglioma. Alliance for Clinical Trials in Oncology sponsors the most, 7.

CMS Open Payments shows 29 general payments to Dr. Galanis from 7 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 62% of the total. Genentech, Inc. paid the most, $22,872.

Dmand AI lists 14 awards for Dr. Galanis, most recently ASCI Member in 2011.

Dr. Galanis graduated from University of Athens in 1990. Dr. Galanis is a member of ASCO.

Dr. Galanis is in network with 17 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.